These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chagas cardiomyopathy--where do we stand after a hundred years? Biolo A; Ribeiro AL; Clausell N Prog Cardiovasc Dis; 2010; 52(4):300-16. PubMed ID: 20109600 [TBL] [Abstract][Full Text] [Related]
10. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe. Vannucchi V; Tomberli B; Zammarchi L; Fornaro A; Castelli G; Pieralli F; Berni A; Yacoub S; Bartoloni A; Olivotto I J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):817-23. PubMed ID: 25022923 [TBL] [Abstract][Full Text] [Related]
18. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285 [TBL] [Abstract][Full Text] [Related]
19. A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease. Dávila DF; Donis JH; Torres A; Ferrer JA Int J Cardiol; 2004 Aug; 96(2):191-5. PubMed ID: 15262032 [TBL] [Abstract][Full Text] [Related]
20. Autonomic neuroimmunomodulation in chagasic cardiomyopathy. Ribeiro Machado MP; Dias da Silva VJ Exp Physiol; 2012 Nov; 97(11):1151-60. PubMed ID: 22581749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]